Myocardial Perfusion Imaging with special consideration of pharmacological stress agents

2

dfp-Punkte

Autor/Referent

Prof. Dr. Richard Underwood
Prof. Dr. François Rouzet
Prof. Dr. Sigmund Silber
Dr. María Nazarena Pizzi

Lernziele

  • To appreciate ESC and NICE guidelines for the investigation of patients presenting with stable chest pain
  • To compare the strengths and weaknesses of non-invasive imaging tests for the investigation of patients presenting with stable chest pain
  • To select appropriate stress for coronary functional imaging according to patient characteristics. 
  • To review aspects of the cost-effectiveness of non-invasive tests of coronary function
  • When evaluating a patient with suspected SCAD it is essential to calculate the pre-test probability to select the appropriate test.
  • Regadenoson is currently the stress test of choice in patients with suspected SCAD, with severe chronic obstructive pulmonary disease and who cannot perform a good exercise test.
  • A stress test performed with Regadenoson has a diagnostic and prognostic yield comparable to other vasodilators or an exercise test.
  • Regadenoson is by far the most practical pharmacological stress protocol (independent of the weight of the patient, short infusion time, few side effects, etc.)
  • Indications for Regadenoson in daily practice
  • Correct use of Regadenoson
  • Procedure for possible complications
  • For diagnostic purpose of CAD, maximal stress is required
  • Whenever 85% maximal predicted HR is not achievable, the combination of exercise with a coronary vasodilator agent is advised
  • Regadenoson offers the possibility to decide upon the opportunity to administrate the vasodilator agent according to the patients’ actual exercise abilities  with only a 30 sec prolongation of the duration of exercise

Lecture Board

Prim. Univ.-Doz. Dr. Alexander Becherer
Univ.-Prof. Dr. Christian Pirich

Fortbildungsanbieter

Landeskrankenhaus Feldkirch
Abteilung für Nuklearmedizin

course type image
dfp-Fortbildung gültig bis 06.05.2022
0%